Sunday, January 13, 2019 12:48:40 PM
The idea here is to be a fully reporting, money gushing enterprise. Let's get to fully reporting now, that way you won't alienate yourself from investors that require transparency before investing.
An investor can't really do an impactful financial analysis of the company as an investment opportunity if they don't have all the information. Most long-term investors need this information to analyze: Liquidity Ratios to determine ability to pay short-term liabilities, Leverage Ratios to determine ability to cover debt, and Valuation Ratios that determine the attractiveness of the current stock price.
We absolutely need these types of investors in DMAN to take these sub-penny shares off our hands for 50 cents. It all starts with REVENUE! Penny stocks can take off like a Roman Candle, but with no REVENUE! to support the share price and all these valuation calculations, the share price is guaranteed to settle back down to where it started as volume dries up.
A good example of this is OW*P. I know some of you made a nice profit off that comapny back in the glorious run it made from October 2016 to February 2017 where it ran from $0.06 cents to $3. Today you can buy all the shares you want for $0.14. I know that a run of this type is very appealing to DMAN shareholders today, but let's take a look at another possible outcome. I'm a longer term investor than most of you here, I've got stocks in my portfolio that I've held for at least 20 years. You can never get to the real profits without using time and compounding as leverage. Look at Premium Brands, Hannan's former company. They went from a penny startup to over $100/share by generating enormous sales.
This is what I see when I look at my shares of DMAN. Back in 2008 Premium Brands paid a $0.098 quarterly dividend. Today the dividend is $0.475 quarterly. Imagine hanging on to 1,000,000 shares for 12 years (sell the rest of your shares for an enormous profit so you can take care of your future, of cousrse!) and have it pay off at the rate of $475,000 per quarter? That's where the real money is. $14MM in dividends over 12 years. See below for dividend history. Also, imagine the income you could generate just by selling way out of the money calls on your 1,000,000 share pile.
Date Div*
12/27/2018 0.475 $475,000.00
9/27/2018 0.475 $475,000.00
6/28/2018 0.475 $475,000.00
3/28/2018 0.475 $475,000.00
12/28/2017 0.42 $420,000.00
9/28/2017 0.42 $420,000.00
6/28/2017 0.42 $420,000.00
3/29/2017 0.42 $420,000.00
12/28/2016 0.38 $380,000.00
9/28/2016 0.38 $380,000.00
6/28/2016 0.38 $380,000.00
3/29/2016 0.38 $380,000.00
12/29/2015 0.345 $345,000.00
9/28/2015 0.345 $345,000.00
6/26/2015 0.345 $345,000.00
3/27/2015 0.345 $345,000.00
12/29/2014 0.313 $313,000.00
9/26/2014 0.313 $313,000.00
6/26/2014 0.313 $313,000.00
3/27/2014 0.313 $313,000.00
12/27/2013 0.313 $313,000.00
9/25/2013 0.313 $313,000.00
6/26/2013 0.313 $313,000.00
3/26/2013 0.294 $294,000.00
12/27/2012 0.294 $294,000.00
9/26/2012 0.294 $294,000.00
6/27/2012 0.294 $294,000.00
3/28/2012 0.294 $294,000.00
12/28/2011 0.294 $294,000.00
9/28/2011 0.294 $294,000.00
6/28/2011 0.294 $294,000.00
3/29/2011 0.294 $294,000.00
12/29/2010 0.294 $294,000.00
9/28/2010 0.294 $294,000.00
6/28/2010 0.294 $294,000.00
3/29/2010 0.294 $294,000.00
12/29/2009 0.294 $294,000.00
9/28/2009 0.294 $294,000.00
6/26/2009 0.098 $98,000.00
5/27/2009 0.098 $98,000.00
4/28/2009 0.098 $98,000.00
3/27/2009 0.098 $98,000.00
2/25/2009 0.098 $98,000.00
1/28/2009 0.098 $98,000.00
12/29/2008 0.098 $98,000.00
11/26/2008 0.098 $98,000.00
10/29/2008 0.098 $98,000.00
9/26/2008 0.098 $98,000.00
8/27/2008 0.098 $98,000.00
$14,159,000.00
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM